The Journal of Clinical Pharmacology《临床药理学杂志》（月刊）. The Journal of Clinical Pharmacology (JCP) is a Human Pharmacology journal designed to provide physicians, pharmacists, research scientists, regulatory scientists, drug developers and academic colleagues a forum to present research in all aspects of Clinical Pharmacology.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY《抗菌化疗杂志》（月刊）. The Journal of Antimicrobial Chemotherapy is a journal of the British Society for Antimicrobial Chemotherapy (BSAC) and is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.

FUNDAMENTAL & CLINICAL PHARMACOLOGY《基础与临床药理学》（双月刊）. Fundamental & Clinical Pharmacology publishes reports describing important and novel developments in fundamental as well as clinical research relevant to drug therapy. Original articles, short communications and reviews are published on all aspects of experimental and clinical pharmacology.

Bangladesh Journal of Pharmacology《孟加拉国药理学杂志》（季刊）. Bangladesh Journal of Pharmacology (Bangladesh J Pharmacol) is an open access, video component, single blinded peer-reviewed journal of the Bangladesh Pharmacological Society (BDPS). We publish Research article, Mini-review, Meta-analysis, Clinical Trial, Visual Experiment and Letter to the Editor. The author will not be charged in the form of submission fee, article processing fee or publication fee. It is completely free. We do not publish any advertisement.

Antimicrobial Agents and Chemotherapy《抗菌剂与化疗》（月刊）. Antimicrobial Agents and Chemotherapy features interdisciplinary studies that build our understanding of the underlying mechanisms and therapeutic applications of antimicrobial and antiparasitic agents and chemotherapy. The journal also publishes studies involving animal models, pharmacological characterization, and clinical trials.

Journal of Pharmacy and Pharmacology《药学与药理学杂志》（月刊）. Journal of Pharmacy and Pharmacology (JPP), one of the leading pharmaceutical sciences journals has been published continuously since 1870 and monthly since 1949. The Journal publishes original research papers, critical reviews and rapid communications on the latest developments in the pharmaceutical sciences.

Journal of Neuroimmune Pharmacology《神经免疫药理学杂志》（一年1卷）. The aims of the Journal of Neuroimmune Pharmacology are to promote the dissemination, interest, and exchange of new and important discoveries for the pharmacology and immunology of the nervous system. Through its publications, the Journal seeks to increase the fundamental understanding of neurologic and neuropsychiatric disorders affected by the immune system or vice versa and towards pharmacologic measures that lead, either to a better understanding of disease mechanisms, or by improving disease outcomes.

Current Pharmaceutical Biotechnology《当代药物生物技术》（一年15期）. Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/mini reviews, original research articles and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome.

CNS Neuroscience & Therapeutics《中枢神经系统神经科学与治疗》（月刊）. CNS Neuroscience & Therapeutics is an Open Access journal offering a medium for rapid publication of original clinical, experimental, and translational research papers, timely reviews and reports of novel findings of therapeutic relevance to the central nervous system.

CANCER CHEMOTHERAPY AND PHARMACOLOGY《肿瘤化疗与药理学》（月刊）. Addressing a wide range of pharmacologic and oncologic concerns on both experimental and clinical levels, Cancer Chemotherapy and Pharmacology is an eminent journal in the field. The primary focus in this rapid publication medium is on new anticancer agents, their experimental screening, preclinical toxicology and pharmacology, single and combined drug administration modalities, and clinical phase I, II and III trials.